Neal Gordon Simon
Gründer bei Azevan Pharmaceuticals, Inc.
Aktive Positionen von Neal Gordon Simon
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Azevan Pharmaceuticals, Inc.
 Azevan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Azevan Pharmaceuticals, Inc. develops novel therapeutics to treat disorders of stress, mood, and behavior. Its first clinical compounds selectively block the effects of arginine vasopressin, a peptide neurohormone involved in the pathophysiology of neuropsychiatric symptoms in neurodegenerative diseases and a broad range of stress-related affective disorders, including Post-traumatic Stress Disorder (PTSD), Intermittent Explosive Disorder, and major depression. The company was founded by Craig F. Ferris and Neal Gordon Simon in 1999 and is headquartered in Bethlehem. | Direktor/Vorstandsmitglied | 15.12.2010 | - |
| Vorstandsvorsitzender | 01.01.1999 | - | |
| Gründer | 01.01.1999 | - |
Karriereverlauf von Neal Gordon Simon
Ehemalige bekannte Positionen von Neal Gordon Simon
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| University of Strasbourg | Corporate Officer/Principal | 01.01.1996 | - |
| Lehigh University | Corporate Officer/Principal | - | - |
Ausbildung von Neal Gordon Simon
| Rutgers State University of New Jersey | Doctorate Degree |
| State University of New York at Binghamton | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| Frankreich | 3 |
Operativ
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sektoral
| Consumer Services | 5 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Azevan Pharmaceuticals, Inc.
Azevan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Azevan Pharmaceuticals, Inc. develops novel therapeutics to treat disorders of stress, mood, and behavior. Its first clinical compounds selectively block the effects of arginine vasopressin, a peptide neurohormone involved in the pathophysiology of neuropsychiatric symptoms in neurodegenerative diseases and a broad range of stress-related affective disorders, including Post-traumatic Stress Disorder (PTSD), Intermittent Explosive Disorder, and major depression. The company was founded by Craig F. Ferris and Neal Gordon Simon in 1999 and is headquartered in Bethlehem. | Health Technology |
- Börse
- Insiders
- Neal Gordon Simon
- Erfahrung
